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1. introduction 
Biochemical [l-3] and immunofluorescent [4,5] 
observationsindicate that actin filaments are disrupted 
in plasma nd serum. An actin depolymerizing protein 
has been partially characterized in human plasma nd 
serum using the abolition of immunofluorescence as 
an assay [4,5]. A more quantitative assay may be 
achieved using the i~ibition of pancreatic DNase I
by actin monomers [6-81. Here, this technique has 
been used to quantitate actin depolymeriz~g activity 
in plasma nd serum and to characterize the stability 
of the factor involved. This factor is labile at 50°C or 
in the presence of papain indicating that it is a protein. 
The amount of actin depolymerized by plasma is 
-100 @g/ml and the activity is unaffected by clotting. 
2. Materials and methods 
Rabbit or chick skeletal muscle actins were pre- 
pared from acetone powders 191. Platelet actin was 
prepared from pro~act~ [lo] by addition of EGTA 
to 5 mM [ 1 l] and sedimentation at 10’ X g. Plasmas 
(platelet-rich and platelet-free) were obtained by dif- 
ferential centrifugation ofpig blood [lo] pooled from 
several animals. Rabbit plasma was obtained by an 
identical procedure. Platelet free plasma could be 
stored at -20°C for several weeks. Serum was prepared 
from plasma by addition of CaClz to 1 mM followed 
by centrifugation to remove the clot. Fresh frozen 
Abbreviation: EGTA, ethyiene glycol his (~~m~oethyl 
ether) ~~~~I-tetraacetic acid 
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human plasma was obtained from The Regional Blood 
Transfusion Centre, Cambridge. 
The DNase inhibition assay for actin depoly- 
merizing activity is described in [8]. F-Actin 
(30-100 nl at 200 pg/ml in 15% glycerol, 30 mM 
NaCl, 20 mM imidazole-HCl pH 7.0) is mixed with 
sample in a 1 ml, 1 cm path spectrophotometer cuvette; 
0.5-l min later l-2 pg DNase are added, followed 
by 0.9 ml DNA (A&jm = 1 .O), at 25OC and in 125 mM 
Tris-HCl @H 7.5), 5 mM MgCIZ, 2 mM CaC12. One 
unit of actin depolymeriz~g activity inhibits a DNase 
activity of 1 AZ6e unit . min-’ . cm-’ by 5%. 
Radiolabelled actin was prepared either by incor- 
poration of [o~-~~P] ADP during polymerization or by 
reaction of F-actin with iodo-[r4Cz]acetamide [7]. 
Sedimentation of Factin in the presence of plasma or 
suitable control buffers (30 mM NaCl, 20 mM imid- 
azole-HCl (pH 7 .O), 1 mM NaNa) was done at 
> 10’ X g in a Beckman airfuge or following addition 
of fdamentous rabbit myosin in an MSE microfuge. 
Aliquots of plasma nd serum treated Factin were 
applied to collodion and carbon~oated copper grids, 
stained with 1% uranyl acetate and observed with a 
Philips 400 electron microscope. 
3. Results 
3 .l . Evidence that filaments are depolymerized in 
plasma 
There are several lines of evidence that actin fila- 
ments are depolymerized in plasma. The best derives 
from the fact that actin monomers produced rapidly 
inhibit DNase activity but F-actin does not [6--81. 
The experiment described in fig.1 shows that plasma 
alone does not inhibit DNase nor have DNase activity; 
however, when plasma is mixed with an excess of 
175 
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20- 
10- 
diluted plasma (~1 ) 
Fig.1. DNase inhibition by pig plasma is dependent on the 
presence of F-actin. (0) Factin 5 ~18 in 100 /.11,30 mM NaCl, 
20 mM imidazole-HCl (pH 7.0) mixed with increasing vol- 
umesof a 1: 10 dilution of pig plasma;after 1 min, 1 pg DNase 
added. (0) Control without Factin; 2 pg DNase mixed with a 
15 dilution of pig plasma. (A) Control without actin or DNase; 
pig plasma diluted 1:s. In all cases, 0.9 ml DNA added. 
Factin,inhibition occurs in proportion to the amount 
of plasma added. This implies that F-actin is converted 
to monomers or into a form which inhibits DNase 
within the time required to set up the assay (<15 s). 
Supporting evidence comes from the observation that 
F-actin labelled either with [cu-“P]ADP or iodo- [14C2l 
acetamide is not sedimented at > 10’ X g in the pres- 
ence of plasma (94% of the radioactive phosphate 
remains in the supernatant compared to 12% in con- 
trols). Nor does the addition of tilamentous myosin 
aid the sedimentation of radioactive actin in plasma 
treated samples. Similar experiments using ‘251-labelled 
F-actin have been reported in [S]. Finally, filaments 
can no longer be visualized by negative staining after 
F-a&in has been mixed with a dialyzed, ammonium 
sulphate fraction (40-60% cut) containing the actin 
depolymerizing activity. Serum is reported to have a 
similar effect [5]. 
The actin depolymerizing activity is not specific 
for the polymorphic form of actin. Rabbit and chick 
skeletal muscle actins which are both a-forms [ 121 
and platelet actin which contains both /3- and r-forms 
[lo] are depolymerized to a similar extent. 
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3.2. Quantitation of theactin depolymerizingcapacity 
of plasma and serum 
The specific activity of pig plasma is typically 
- 1 unit/mg protein and 60 units/ml (table I). This 
corresponds to - 100 c(g actin depolymerized/ml 
plasma. Clotting of platelet-rich or platelet-free pig 
plasma had no significant effect on the level of actin- 
depolymerizing activity remaining in the serum. 
Somewhat lower activities were measured for human 
and rabbit plasma. 
3.3. Characterization of the depolymerizing factor 
The actin depolymerizing factor was partially puri- 
fied following exhaustive dialysis in 0.14 M NaCl, 
20 mM imidazole-HCl (pH 7 .O) (100% activity recov- 
ered), by ammonium sulphate fractionation (30-40% 
cut) and gel filtration on Sephadex G-100 in the same 
buffer. The activity eluted with M, = 100 000 and a 
S-fold enhancement of specific activity was achieved. 
Actin depolymerizing activity was destroyed when this 
material was incubated with papain (l/150, w/w, at 
25’C) with a tr12 of 16 min. 
The depolymerizing activity is heat-labile. In agree- 
ment with [5] activity was completely destroyed 
Table 1 
Quantitation of actin depolymerizing activity in plasma 
and serum 
Sample No. Specific activity Actin 
used depolymerized 
(units/mg) (units/ml) (pg/ml) 
Pig plasma 1 1.51 81.3 132 
Pig plasma 7 1.16tO.24 63.6*14.3 10la 
Rabbit plasma 1 22.0 35.7a 
Human plasma 5 0.72kO.09 38.52 2.2 62.6a 
Platelet-rich 
plasma-derived 1 80.62 4.0 131a 
serum (pig) 
Platelet-free 
plasmaderived 1 
serum (pie) 
83.3+ 4.2 13Sa 
Control plasma 
for serum 1 75.3* 3.8 122a 
samples (pig) 
a Calculated from the activity of the first plasma sample which 
was calibrated with a standard G-actin solution 
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Fig.2. Heat inactivation of plasma actin depolymerizmg activ- 
ity. Partially purified depolymerization factor (see text) was 
incubated at Sl’C in 0.14 M NaCl, 20 mM imklazole-HCl 
(pH7.0) wthout addition (e),with 20%8lycerol(O),or with 
1 mM CaCl, (A). At intervals, aliquots (50 ~1) were assayed 
for DNase lnhibition using 100 ~1 Factin (0.23 mg/ml) and 
2 Mg DNase. 
within 30 mm at 56°C. Using the partially purified 
material described above, no decay in activity was 
observed at 40°C over 40 mm. Fig.2 showscx~~ments 
at 5 X”C where the t,,, of I2 mm is increased to 3 1 mm 
in the presence of 20% glycerol and 1 mM CaCIZ 
provides complete stabilization over 40 min. Further 
experrments showed that the c,,a was -2.5 hin 
10” M CaCl, but 10” M CaCla provided no stabiliza- 
tion. 
4. Discussion 
[libation of pancreatic DNase by de~lymc~zed 
actin providesa qu~titat~ve meansof measuring actin 
depolymerizing activity. The assay may be used with 
muscle or non-muscle F-actin and functions in the 
presence of complex biological fluids such as plasma. 
Partial purification of the depolymerizing activity in 
plasma indicates that the active component is a protein 
of 100 OOOM, which is labile to heating at 51°C but 
stabilized under these conditions in the presence of 
10”’ M CaC12. An intracellular act~depolymeriz~ng 
protein @&<I35 000) isolated from brain has been 
reported in [f 31. fn contrast o the plasma protein, 
Ca” increase the heat-lab~ty of this brain factor. 
The DNase assay shows that pig plasma contains uffi- 
cient factor to depolymerize 100% F-a&in/ml. Similar 
quantitation [I 3] of the amount of factor in chick 
embryo brairr indicates that up to 400 fig F-a&in can 
be depolymerized/g brain tissue. 
Whilst the function of the brain depolymerizing 
protein may be to aid in the recycling of intracellular 
F-actin, the reason for the presence of such a factor 
in plasma remains unclear. It may serve to disassemble 
filamentous actin released by platelets or other blood 
cells since the highly viscous nature of Factin would 
be deleterious to blood Row through the capillaries. 
Alternatively the protein may be transported in the 
blood and taken up into cells. 
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